Evidence map›Paper›PMID 40681347›Full record

ArticleAging and disease2025

The Cognitive Functions Dementia Battery: A Novel Computerized Tool for Neurocognitive Disorders.

Raquel Lemos, Sofia Areias-Marques, Alexandros Lazaridis, Johanna Zils, Cristina Martins, Sílvia Almeida, Luísa Alves, David Brieber, Albino J Oliveira-Maia

Abstract read
In one paragraph

Article in Aging and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Raquel LemosChampalimaud Research & Clinical Centre, Champalimaud Foundation, Lisboa, Portugal.
Sofia Areias-MarquesChampalimaud Research & Clinical Centre, Champalimaud Foundation, Lisboa, Portugal.
Alexandros LazaridisSCHUHFRIED GmbH, Mödling, Austria.
Johanna ZilsSCHUHFRIED GmbH, Mödling, Austria.
Cristina MartinsCELGA-ILTEC, Faculdade de Letras da Universidade de Coimbra, Coimbra, Portugal.
Sílvia AlmeidaChampalimaud Research & Clinical Centre, Champalimaud Foundation, Lisboa, Portugal.
Luísa AlvesHospital de Egas Moniz, Unidade Local de Saúde de Lisboa Ocidental, Lisboa, Portugal.
David BrieberSCHUHFRIED GmbH, Mödling, Austria.
Albino J Oliveira-MaiaChampalimaud Research & Clinical Centre, Champalimaud Foundation, Lisboa, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Cognitive Functions Dementia (CFD) is a computerized battery to assess the cognitive domains included in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for neurocognitive disorders. We aimed at examining the psychometric properties and the clinical validity of the CFD for neurocognitive disorders. Psychometric characterization was conducted in healthy individuals, stratified according to age, sex, and education to represent a norming sample. Analyses included structural validity and measurement invariance, assessed through confirmatory factor analyses (CFA) and multi-group CFA, as well as internal consistency, and re-test reliability of the battery index values. Patients with major or minor neurocognitive disorder contributed data to compute receiver operating characteristics to assess diagnostic accuracy of the CFD indices relative to healthy participants. Data from 422 healthy volunteers and 81 patients were collected for the study. The confirmatory factor analysis model confirmed the validity of the structure proposed for CFD, with the five cognitive domains (attention, verbal long-term memory, expressive language, executive functions, and perceptual motor functions) describing an overall factor (CFD-Index). Good to excellent values of internal consistency and of re-test reliability were obtained for all indices. Importantly, CFD indexes were accurate in discriminating patients with neurocognitive disorders from healthy participants. The CFD battery is a valid and reliable computerized instrument to characterize patients with neurocognitive dysfunction.

Indexed as

CognitionDementiaDiagnosis, Computer-AssistedNeurocognitive DisordersNeuropsychological TestsAdultAgedAged, 80 and overFactor Analysis, StatisticalFemaleHumansMaleMiddle AgedPsychometricsReproducibility of Results

Identifiers

PMID40681347
PMCPMC13061557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.